Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reventics is a healthcare technology and services company focused on clinical documentation improvement and revenue cycle management for healthcare providers. The company developed provider engagement solutions intended to improve physician documentation, coding accuracy, reimbursement, compliance, and clinical quality measures. Its offerings include proprietary cloud-native products such as RevCDI and RevMAX, combined with physician-led and analytics-driven service delivery. Founded in 2016 in Colorado, Reventics was acquired by Omega Healthcare in March 2022 and appears to continue operating as part of Omega's broader healthcare operations platform. It is not a drug-development biotech or pharma company; rather, it serves the healthcare provider ecosystem through software-enabled operational and financial workflow solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reventics.